News Coverage 11.13.19 By: Marta Figueiredo Share on Twitter Share on Facebook Share on LinkedIn CRISPR-edited T-cells Safely, Effectively Target Cancer Cells in Myeloma Patients, Early Phase 1 Data Suggests Related Announcement, Press Release PICI Welcomes Aimee Johnson as Chief Marketing Officer Announcement, Press Release PICI Network Shapes Future of Immunotherapy at AACR 202 Announcement, Press Release PICI and CVC Unite to Accelerate Cancer Vaccines